Should the use of contralateral prophylactic mastectomy be increasing as it is?

Breast

Volumn 18, Issue SUPPL.3, 2009, Pages

  Wood, William C ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Breast cancer; Contralateral prophylactic mastectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMAGE ANALYSIS; MASTECTOMY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURGICAL ANATOMY; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 71749100422     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(09)70282-6     Document Type: Article

References (32)

1. Grotius, Hugo. The laws of war and peace. 1625 A.D.
2. Montgomery L.L., Tran K.N., Heelan M.C., et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol 6 (1999) 546-552
3. Bostwick III J., and Wood W.C. Editorial: Contralateral prophylactic mastectomies. Ann Surg Oncol 6 (1999) 519
4. Tuttle T.M., Habermann E.B., Grund E.H., et al. Increasing use of contralateral mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25 (2007) 5203-5209
5. Tuttle T.M., Jarosek S., Haberman E.B., et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol (2008) 10.1200/JCO.2008.20.1681
6. Recht A. Contralateral prophylactic mastectomy: Caveat emptor. J Clin Oncol (2008) 10/1200/JCO.2008.21.0518
7. Jones N.B., Kotur L., Wilson J., et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend. Ann Surg Oncol 16 (2009) A17
8. Lee M.C., McGuire K.P., Carter W.B., et al. Factors influencing the choice of prophylactic mastectomy. Ann Surg Oncol 16 (2009) P84
9. Ahrendt G.M., Sorbero M.E., Beckjord E., et al. Contralateral prophylactic mastectomy associated with the use of MRI for early stage breast cancer. Ann Surg Oncol 16 (2009) 85
10. Metcalfe K., Lynch H.T., Ghadirian P., et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22 (2004) 2328-2335
11. Adami H.O., Bergstrom R., and Hansen J. Age at first primary as a determinant of bilateral breast cancer: Cumulative and relative risks in a population based casecontrol study. Cancer 55 (1985) 643-647
12. Storm H.H., and Jensen O.M. Risk of contralateral breast cancer in Denmark, 1943-1980. Br J Cancer 54 (1986) 483-492
13. Gronwald J., Tung N., Foulkes W.D., et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118 (2006) 2281-2284
14. Eisen A., Lubinski J., Klijn J., et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international casecontrol study. J Clin Oncol 23 (2005) 7491-7496
15. Robbins G.F., and Berg J.W. Bilateral primary breast cancer, a prospective clinicopathological study. Cancer 17 (1964) 1501-1527
16. Gogas J., Markopoulos C., Skandalakis P., et al. Bilateral breast cancer. Am Surg 59 (1993) 733-735
17. Yeatman T.J., Lyman G.H., Smith S.K., et al. Bilaterality and recurrence rates for lobular breast cancer: considerations of treatment. Ann Surg Oncol 4 (1997) 198-202
18. Chung M.A., Bold B., Wanebo H.J., et al. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4 (1997) 545-550
19. Peiro G., Bornstein B.A., Connolly J.L., et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59 (2000) 49-54
20. Djordjevic N, Karanikolic A, Pesic M, et al. Salient characteristics of infiltrating ductal carcinoma and invasive lobular carcinoma of the breast. 2004; P285.
21. Vo T.N., Meric-Bernstam F., Yi M., et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192 (2006) 552-555
22. Boughey J.C., Khakpour N., Meric-Bernstam F., et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107 (2006) 1440-1447
23. Lostumbo L., Carbine N., Wallace J., and Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 18 (2004) CD002748.
24. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film screen mammography for breast-cancer screening. N Eng J Med 353 (2005) 1773-1783
25. Lehman C.D., Blume J.D., and Thickman D. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the IBMC trial. J Surg Oncol 92 (2005) 1-16
26. Eisen A., Rebbeck T.R., Wood W.C., et al. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18 (2000) 1980-1995
27. Hartmann L.C., Schaid D.J., Woods J.E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 (1999) 77-84
28. Helzlsouer K.J. Editorial: Contralateral prophylactic mastectomy: quantifying the benefits and weighing the harms. J Clin Oncol 23 (2005) 4251-4253
29. Frost M.H., Slezak J.M., Tran N.V., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23 (2005) 7849-7856
30. Rolnick S.J., Altschuler A., Nekhlyudov L., et al. What women wish they knew before prophylactic mastectomy. Cancer Nurs 30 (2007) 285-291
31. Altschuler A., Nekhlyudov L., Rolnick S.J., et al. Positive, negative, and disparate - women's differing long-term psyschosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14 (2008) 25-32
32. Soran A., Falk J., Bonaventura M., et al. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic masectomy? Magee-Womens Hospital experience. Ann Surg Oncol 14 (2007) 646-651